⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN 2-WEEK DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - HBSS
globenewswire.com
REGN
Shareholders of Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
Pomerantz LLP Shares Class Action Details With Shareholders in Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Non-Melanoma Skin Cancer Market: Focus on Disease Indication, Treatment Type, Country and Region, 2025-2035
globenewswire.com
AMGN
REGN
Europe Hyperscale Data Center Market Outlook & Forecast 2026-2031 | AI and Cloud Adoption Accelerate Europe's Data Center Expansion
globenewswire.com
ORCL
GOOGL
AMZN
AAPL
MSFT
DELL
HPE
NVDA
CSCO
ETN
SWKS
ADI
QCOM
AVGO
INTC
AMD
MU
AMAT
KLAC
LRCX
VRTX
GILD
BMY
PFE
MRNA
REGN
BIIB
ABBV
AMGN
ISRG
MDT
SYK
EW
GOOG
GOOGN
Levi & Korsinsky Urges Regeneron (REGN) Shareholders to Act Before Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
Pomerantz LLP Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit – REGN
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN